Tinavi Medical Technologies Co Ltd (688277) — Net Asset Quality Index
Tinavi Medical Technologies Co Ltd (688277) has a Net Asset Quality Index of 72.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.64 Billion minus total liabilities of CN¥451.55 Million yields net assets of CN¥1.19 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Tinavi Medical Technologies Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tinavi Medical Technologies Co Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how Tinavi Medical Technologies Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 72.5%, representing net assets of CN¥1.19 Billion against total assets of CN¥1.64 Billion CNY. See Tinavi Medical Technologies Co Ltd (688277) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tinavi Medical Technologies Co Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Tinavi Medical Technologies Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 688277 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 175.4% | CN¥3.01 Billion | CN¥1.71 Billion | CN¥-1.29 Billion | ▲ +99.7 pp |
| 2024 | 75.7% | CN¥1.28 Billion | CN¥1.69 Billion | CN¥411.58 Million | ▼ -0.7 pp |
| 2023 | 76.4% | CN¥1.24 Billion | CN¥1.62 Billion | CN¥381.95 Million | ▼ -3.0 pp |
| 2022 | 79.4% | CN¥1.12 Billion | CN¥1.41 Billion | CN¥289.39 Million | ▼ -4.0 pp |
| 2021 | 83.5% | CN¥1.07 Billion | CN¥1.28 Billion | CN¥211.48 Million | ▼ -8.2 pp |
| 2020 | 91.7% | CN¥1.03 Billion | CN¥1.12 Billion | CN¥92.73 Million | ▲ +8.1 pp |
| 2019 | 83.6% | CN¥596.34 Million | CN¥713.60 Million | CN¥117.26 Million | ▼ -1.0 pp |
| 2018 | 84.6% | CN¥560.61 Million | CN¥662.66 Million | CN¥102.05 Million | ▲ +57.4 pp |
| 2017 | 27.2% | CN¥169.41 Million | CN¥622.67 Million | CN¥453.26 Million | ▼ -46.3 pp |
| 2016 | 73.5% | CN¥136.62 Million | CN¥185.77 Million | CN¥49.16 Million | ▼ -22.7 pp |
| 2015 | 96.2% | CN¥203.98 Million | CN¥211.96 Million | CN¥7.98 Million | ▲ +17.5 pp |
| 2014 | 78.8% | CN¥52.84 Million | CN¥67.09 Million | CN¥14.25 Million | ▲ +7.2 pp |
| 2013 | 71.6% | CN¥29.60 Million | CN¥41.36 Million | CN¥11.76 Million | — |